GET DAILY SIGNALSHIVE vs WULF: Weighing Two Bitcoin Miners Shifting Toward AI Infrastructure
Key Takeaways
- Both HIVE and WULF are moving from Bitcoin mining into AI and high-performance computing infrastructure, though their scales and capital structures differ markedly.
- HIVE has landed multi-year GPU cloud contracts via its BUZZ HPC unit, while WULF maintains a substantially larger contracted backlog that includes a long-term lease with Anthropic.
- Both stocks hold "Strong Buy" analyst ratings, yet each has experienced notable multi-month declines amid volatility in AI infrastructure and crypto markets.
- Tickeron AI Verdict: HIVE — its lower leverage and more immediate revenue visibility give it a relatively stronger risk-adjusted profile at present.
- For more context, review HIVE Major News and HIVE Today's Price Move, along with WULF Major News and WULF Today's Price Move.
Setting the Context for These Two Names
HIVE Digital Technologies (HIVE) and TeraWulf (WULF) both started as Bitcoin miners and are now competing for a share of the AI computing opportunity. Their share prices have fluctuated noticeably in recent weeks, making a direct comparison useful for assessing relative positioning, performance, and risk. This is particularly relevant for investors following the overlap between cryptocurrency operations and artificial-intelligence infrastructure, where factors like contracted revenue and financing needs are becoming key differentiators.
HIVE's Dual Strategy and Market Moves
HIVE Digital Technologies Ltd. develops and runs data centers using renewable energy in locations including Canada, Sweden, Iceland, and Paraguay. The firm follows a dual approach, maintaining Bitcoin mining while expanding its AI and HPC operations through the BUZZ HPC subsidiary. Recent GPU cloud contracts include an agreement around $220 million and a five-year deal near $350 million, which management indicates could push BUZZ HPC's annualized recurring revenue close to $180 million. Additional project financing has been arranged to support further NVIDIA GPU deployments.
The stock has remained volatile despite this progress. After trading above $5 earlier in the year, HIVE has retreated into the low single digits recently, well below its 52-week high. Ongoing GAAP losses, potential dilution from an at-the-market program, and a tax matter in Sweden have weighed on sentiment. I also checked this using Tickeron’s AI Screener to compare the stock against peers in the sector. Analysts still maintain a "Strong Buy" consensus, with targets suggesting meaningful upside assuming execution continues as planned.
WULF's Larger Scale and Financing Challenges
TeraWulf Inc. owns, develops, and operates large-scale digital infrastructure in the United States, with headquarters in Easton, Maryland. The company has shifted focus from Bitcoin mining to AI and HPC hosting. Its Lake Mariner campus in New York and Justified Data Campus in Kentucky support a pipeline that includes a 20-year lease with Anthropic and capacity leased to Fluidstack, an AI cloud provider backed by Google. Management has noted that the Anthropic agreement could generate roughly $19 billion in revenue over its duration.
Even with these developments, WULF has undergone a sharp correction, declining more than 60% from its 52-week high in recent months and briefly reaching a six-month weekly low before recovering. The pullback stems primarily from financing considerations, including debt needed for capacity expansion, negative free cash flow, and execution risks. Like HIVE, it carries a "Strong Buy" consensus, although its balance sheet shows significantly higher leverage.
Head-to-Head Comparison
The two companies operate at very different scales. WULF is substantially larger, with a multi-billion-dollar market capitalization and a correspondingly bigger contracted backlog, but it also carries multi-billion-dollar debt and has recorded large net losses partly linked to warrant revaluations. HIVE is smaller, with a market cap below $1 billion, yet its leverage relative to equity is lower and its revenue base is expanding quickly from a modest starting point.
HIVE's near-term narrative centers on converting signed GPU contracts into actual revenue, whereas WULF's depends on securing funding and completing major buildouts for tenants like Anthropic. Both remain exposed to Bitcoin price movements and the broader AI infrastructure theme, though WULF exhibits higher sensitivity to financing costs. Recent momentum shows corrections for both, with HIVE's decline appearing somewhat milder relative to its peak and its price-to-sales valuation screening more moderate.
Tickeron AI Verdict
Considering factors such as trend consistency, relative leverage, revenue visibility, and financing risk, Tickeron's AI currently favors HIVE over WULF. HIVE's more conservative capital structure, sequence of near-term GPU contracts, and less stretched valuation relative to sales point to a steadier risk profile in this volatile sector. WULF's larger backlog is appealing, but its heavier debt and buildout dependencies introduce greater variability. This view is probabilistic and reflects present conditions rather than a forecast of future results.
Exploring Automated Strategies
When evaluating names like these, I find it helpful to review systematic approaches alongside traditional analysis. Tickeron’s Trending AI Robots page provides a focused selection of automated trading strategies that cover thousands of tickers, each with defined styles, timeframes, and performance data. Only the strongest bots for current conditions are highlighted, allowing investors to match strategies to their own risk tolerance and objectives without sifting through an exhaustive list.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HIVE's RSI Oscillator stoops into oversold zone
The RSI Indicator for HIVE moved into overbought territory on October 30, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 64 cases where HIVE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for HIVE just turned positive on October 29, 2026. Looking at past instances where HIVE's MACD turned positive, the stock continued to rise in 30 of 38 cases over the following month. The odds of a continued upward trend are 79%.
Following a +11.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 213 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 69 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for HIVE entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.108). P/E Ratio (9.174) is within average values for comparable stocks, (6.904). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.800) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers
Advertisement